Tumor necrosis factor-α decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes

Critical Care Medicine

Volumn 38, Issue 1, 2010, Pages 217-222

  Kao, Yu Hsun ^a   Chen, Yao Chang ^b   Cheng, Chen Chuan ^c   Lee, Ting I ^a   Chen, Yi Jen ^a,d   Chen, Shih Ann ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cardiomyocyte; Heart failure; Inflammation; Methylation; Tumor necrosis factor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ASCORBIC ACID; DNA METHYLTRANSFERASE; I KAPPA B; RNA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA; CALCIUM;

ANIMAL CELL; ARTICLE; ATTENUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HEART DISEASE; HEART MUSCLE CELL; IMMUNOBLOTTING; INHIBITION KINETICS; METHYLATION; MODULATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; ANIMAL; APOPTOSIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DNA METHYLATION; DRUG EFFECT; GENETICS; HEART ATRIUM; METABOLISM; NORTHERN BLOTTING; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CALCIUM; CELLS, CULTURED; DNA METHYLATION; GENE EXPRESSION REGULATION; HEART ATRIA; MICE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SENSITIVITY AND SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74049128799     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b4a854     Document Type: Article

References (36)

1. Meyer M, Schillinger W, Pieske B, et al: Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995; 92:778-784
2. Zarain-Herzberg A, Afzal N, Elimban V, et al: Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarc-tion. Mol Cell Biochem 1996; 163-164: 285-290
3. Inesi G, Prasad AM, Pilankatta R: The Ca2+ ATPase of cardiac sarcoplasmic reticulum: Physiological role and relevance to diseases. Biochem Biophys Res Commun 2008; 369: 182-187
4. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241
5. Low-Friedrich I, Weisensee D, Mitrou P, et al: Cytokines induce stress protein formation in cultured cardiac myocytes. Basic Res Cardiol 1992; 87:12-18
6. Yokoyama T, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clinical Invest 1993; 92:2303-2312
7. Packer M: Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995; 92: 1379-1382
8. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
9. Lee SH, Chen YC, Chen YJ, et al: Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci 2007; 80: 1806-1815
10. Kubota T, Bounoutas GS, Miyagishima M, et al: Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 2000; 101:2518-2525
11. Matouk CC, Marsden PA: Epigenetic regulation of vascular endothelial gene expression. Circ Res 2008; 102:873-887
12. Prokhortchouk E, Defossez P-A: The cell biology of DNA methylation in mammals. Bio-chim Biophys Acta Mol Cell Res 2008; 1783: 2167-2173
13. Weitzman SA, Turk PW, Milkowski DH, et al: Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci U S A 1994; 91:1261-1264
14. Stenvinkel P, Karimi M, Johansson S, et al: Impact of inflammation on epigenetic DNA methylation-a novel risk factor for cardiovascular disease? J Intern Med 2007; 261: 488-499
15. Lund G, Zaina S: Atherosclerosis, lipids, inflammation and epigenetics. Curr Opin Lipi-dol 2007; 18:699-701
16. Kang GH, Lee HJ, Hwang KS, et al: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003; 163:1551-1556
17. Wu Y, Strawn E, Basir Z, et al: Promoter hy-permethylation of progesterone receptor iso-form B (PR-B) in endometriosis. Epigenetics 2006; 1:106-111
18. Sun Z, Andersson R: NF-kappaB activation and inhibition: a review. Shock 2002; 18: 99-106
19. Baud V, Karin M: Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001; 11:372-377
20. Schreck R, Baeuerle PA: A role for oxygen radicals as second messengers. Trends Cell Biol 1991; 1(2-3):39-42
21. White SM, Constantin PE, Claycomb WC: Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 2004; 286:H823-H829
22. Lin Y-Z, Yao S, Veach RA, et al: Inhibition of Nuclear Translocation of Transcription Factor NF-[IMAGE]B by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence. J Biol Chem 1995; 270:14255-14258
23. Schmelzer C, Lindner I, Rimbach G, et al: Functions of coenzyme Q10 in inflammation and gene expression. BioFactors 2008; 32: 179-183
24. Lee T-I, Kao YH, Chen YC, et al: Proinflam-matory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors. Eur J Clin Invest 2009; 39:23-30
25. Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427-1431
26. Wongcharoen W, Chen Y-C, Chen Y-J, et al: Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity. Cardio-vasc Res 2006; 70:497-508
27. Dibbs ZI, Diwan A, Nemoto S, et al: Targeted overexpression of transmembrane tumor necrosis factor provokes a concentric cardiac hypertrophic phenotype. Circulation 2003; 108:1002-1008
28. Giroir BP, Johnson JH, Brown T, et al: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 1992; 90:693-698
29. Kapadia S, Lee J, Torre-Amione G, et al: Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995; 96:1042-1052
30. Torre-Amione G, Kapadia S, Lee J, et al: Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 1996; 93:704-711
31. Habib FM, Springall DR, Davies GJ, et al: Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 1996; 347:1151-1155
32. Doyama K, Fujiwara H, Fukumoto M, et al: Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 1996; 54:217-225
33. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-978
34. Gosden RG, Feinberg AP: Genetics and epigenetics-nature's pen-and-pencil set. N Engl J Med 2007; 356:731-733
35. Palii SS, Van Emburgh BO, Sankpal UT, et al: DNA methylation inhibitor 5-Aza-2'-deoxy-cytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol 2008; 28:752-771
36. Gomyo Y, Sasaki J, Branch C, et al: 5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells. Oncogene 2004; 23:6779-6787